15 July 2022 - The Government is wielding excessive power to lower drug prices without recognising the values of innovative medicines, an expert said.
Kim Sung-ju, an expert advisor for Lee & Ko's Healthcare Practice Group, published an article in the Korea Pharmaceutical and Bio-Pharma Manufacturers Association's policy report on Friday.